Dr Charles Vega believes that primary care will be the chief clinical setting for application of new blood-based biomarkers.
Weill Cornell Medicine researchers have received a five-year $6.2 million grant from the National Institute on Aging, part of the National Institutes of Health, to build a portable, high-resolution ...
Amyloid alone does not confirm that Alzheimer's disease is progressing rapidly. Here's what people need to know about the ...
King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia Limited (Lilly) have signed a ...
Alzheimer disease (AD) is the sixth leading cause of death in the United States and is projected to affect over 13 million ...
An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...
Healthy obesity is defined as having a BMI of 25 kg/m² or higher without metabolic diseases or with only one metabolic ...
Eli Lilly Saudi Arabia and King Faisal Specialist Hospital & Research Centre (KFSHRC) have teamed up to make KFSHRC’s Neuroscience Centre a top regional hub for Alzheimer’s disease treatment.
RIYADH, Saudi Arabia, Nov. 03, 2024 (GLOBE NEWSWIRE) -- (KFSHRC) and Eli Lilly Saudi Arabia signed an MoU today to improve ...